Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Phase 2
Completed
- Conditions
- Familial Partial Lipodystrophy
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Abhimanyu Garg
- Target Recruit Count
- 10
- Registration Number
- NCT02430077
- Locations
- 🇺🇸
UT Southwestern Medical Center 5323 Harry Hines Blvd, Dallas, Texas, United States
🇺🇸UT Southwestern Medical Center, Dallas, Texas, United States
News
No news found